NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)

Active
Yes
Status
Posted
Published Date
March 19th, 2024
Close Date
August 19th, 2024
Opportunity No.
RFA-RM-24-003

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) is offering the NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) grant opportunity. This grant aims to support early stage investigators who propose bold and highly innovative research projects with the potential to make a significant impact on important areas relevant to the mission of NIH. The program encourages applications from individuals from diverse backgrounds and institutions across all geographic locations. The grant is open to various topics, including behavioral, social, biomedical, applied, and formal sciences, as well as basic, translational, or clinical research. The NIH Directors New Innovator Award Program is part of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund. For more information and to apply, visit the following link: NIH Directors New Innovator Award Program.

Description

The NIH Directors New Innovator Award Program supports early stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. To support innovative and novel research across the vast NIH mission, individuals from diverse backgrounds (including those from underrepresented groups; see Notice of NIHs Interest in Diversity) and from the full spectrum of eligible institutions in all geographic locations are encouraged to apply to this Notice of Funding Opportunity. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's New Innovator Award Program complements other ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators. The NIH Directors New Innovator Award Program is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.

Contact Information

Attachments
0 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIAID New Innovators Awards grant opportunity. This grant supports postdoctoral and other candidates in non-independent positions or newly independent Early Stage Investigators who propose innovative research concepts in biomedical research. The grant aims to fund projects that have the potential to produce a major impact, test scientific paradigms, or advance key concepts in priority areas for NIAID. The grant encourages applications that propose unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies. Individuals with diverse backgrounds and research topics relevant to the mission of NIAID are welcome to apply. The grant does not require cost sharing or matching funds. The deadline for applications is October 10, 2025. For more information and to apply, visit the following link: [NIAID New Innovators Awards Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-198.html).
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) grant opportunity. This grant supports individual scientists who propose bold and highly innovative research projects with the potential to make a major impact on important areas relevant to the mission of NIH. The grant aims to encourage individuals from diverse backgrounds and institutions across all geographic locations to apply. The funding is open to various topics in the behavioral, social, biomedical, applied, and formal sciences, including basic, translational, or clinical research. The NIH Directors Pioneer Award is part of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund. The grant has a maximum award ceiling of $700,000. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) entities and components are not eligible to apply. The closing date for applications is September 9, 2024. For more information and to apply, visit the following link: [NIH Directors Pioneer Award Program](http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-24-002.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIH Directors Early Independence Awards through a Grant opportunity. This funding is aimed at supporting junior investigators who want to pursue independent research immediately after completing their terminal doctoral degree or post-graduate clinical training. The goal is to accelerate their entry into an independent research career by forgoing the traditional post-doctoral training period. The NIH is particularly interested in supporting researchers from diverse backgrounds, including those from underrepresented groups, and from eligible institutions in all geographic locations. The NIH Directors Early Independence Awards are part of the High-Risk, High-Reward Research program of the NIH Common Fund. The awards are open to applicants from various fields, including behavioral, social, biomedical, applied, and formal sciences, as well as basic, translational, or clinical research. The funding does not require cost sharing or matching requirements. The maximum award ceiling for this grant is $250,000. The closing date for applications is September 6, 2024. For more information and to apply, interested parties can visit the following website: [NIH Directors Early Independence Awards](http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-24-005.html). Please note that eligibility is not limited to domestic organizations, as non-domestic (non-U.S.) entities are also eligible to apply. However, foreign organizations and non-domestic components of U.S. organizations are not eligible to apply. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.